We're excited to continue to support @freenome in accelerating its efforts to bring earlier cancer detection to the market and commercialize the first liquid biopsy test on its platform.
We’re proud to announce that we’ve raised an additional $300M to advance our multiomics platform for #earlycancerdetection. We appreciate our investors and our shared belief in what’s possible when it comes to fighting #cancer.
https://t.co/HBLjM2kzxO
We're excited to announce our strategic investment in @holmusk - reinventing behavioral health through real world evidence generation for research, innovative care and better access for patients.
We're excited to announce the closing of our strategic investment round and to welcome aboard key pharma and provider leaders as new investors, incl. Novartis (dRx Capital) and Northwell Holdings, the venture investment arm of @NorthwellHealth. More: https://t.co/LPGDlLdfxB
Congratulations to @Pear_Tx, @Corey_M_McCann and the entire team for completing the listing - a true inflection point for the entire digital therapeutics industry!
Today, we’re thrilled to share that Pear is officially listed on the @NASDAQ as $PEAR. Thank you to our patients, employees, customers & investors who have supported us through this journey. #NasdaqListed
Congratulations @CalaHealth! dRx Capital is proud to continue to be a partner as Cala transforms the standard of care for chronic disease through novel neuromodulation therapies.
We are excited to share that #CalaHealth has closed our latest funding round raising $77 million!🥳You can learn more about this huge milestone on https://t.co/bVPTWo2aw9
Congratulations Ariel Katz, Ian Sax and the entire @H1co_ team on the $100M Series C led by Altimeter Capital & @GoldmanSachs!
We’re thrilled to continue to partner w/ H1 - reimagining how the life sciences industry engages their most critical customers: patients & clinicians.
Since the very start, H1 has believed in providing a trusted single source of truth for healthcare professional information that will power connections in healthcare - and that these connections will lead us to a healthier future.
#seriesC
https://t.co/lxwhlrwZRh
Excited to announce that portfolio company
@mekonosinc has closed its $25 million Series A led by Magnetar Capital, @section32vc, @DebiopharmNews, @TDKVentures, Sands Capital, and including participation from existing investors.
C&GT manufacturing on a chip!
Mekonos raises $25M oversubscribed round to overcome cell & gene delivery hurdles, expand partnerships, and support talent acquisition https://t.co/v73jcG59DQ
Science 37, the Operating System for today’s #agileclinicaltrials, is now a publicly traded company under ticker symbol SNCE.
Learn more. https://t.co/tkCWAWDCBN
“https://t.co/rVsN0ugbcG aligns with our ambition to reimagine customer engagement for the New Normal.”
-Rana Lonnen, Managing Director at dRx Capital, the Novartis Data and Digital Health Venture Fund
https://t.co/8EIcWWi50N
@dRxCapital
“https://t.co/nH6ugmRLDJ aligns with our ambition to reimagine customer engagement for the New Normal.” ~Rana Lonnen, PhD Managing Director, @dRxCapital@dRxCapital / @Novartis participates with @MCK_Ventures + @LillyPad in $33m strategic financing round.
Proud to partner with forward-looking organizations to help the life sciences industry accelerate the future of working with customers!
https://t.co/8EIcWWi50N
#lifesciences#funding
Join us in discussion with Alasdair Stewart, Digital Medical Engagement Director @Novartis & @davidplogue SVP Strategy & GM Life Sciences https://t.co/rVsN0ugbcG, about the ongoing shift towards omnichannel engagement & how it impacts Medical Affairs.
https://t.co/8W9Fm8IYZ6
@Science37x announces its intention to go public in a deal valued at $1.05 billion.
dRx Capital has been a partner with the company since its Series A and is participating in the PIPE transaction alongside new and existing strategic and institutional investors.
Congratulations to @SomaLogic on taking steps to become a public company!
@novartis has been a partner since 2011 and is participating in the PIPE transaction alongside @TRowePrice@cascapital@softbank@illuminaventure @JHIAdvisorsUS
A special-purpose acquisition company focused on life sciences is nearing a deal to merge with protein-analysis company SomaLogic https://t.co/F8sggYqVEG
As we approach the end of Q1 - some thoughts on digital health & bioIT innovation from dRx Capital Managing Director, Neil Tiwari and Novartis Global Head of Digital BD&L, Jeremy Sohn.
https://t.co/91AANknd2D